The pharmacology of AMPA receptors and their antagonists.
Sheardown
M J
MJ
Novo Nordisk A/S, Pharmaceuticals Research, Måløv, Denmark.
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D000818:Animals; D001921:Brain / Q000378:metabolism; D011810:Quinoxalines / Q000378:metabolism / Q000494:pharmacology; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000378:metabolism
D011810:Quinoxalines; D018091:Receptors, AMPA; C062865:2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline; C056723:FG 9041; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid